


Searching News Database: Replidyne
HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
HSMN NewsFeed - 26 Dec 2006
Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
HSMN NewsFeed - 15 Nov 2006
Replidyne Appoints Vice President, Manufacturing and Director, Investor Relations
Replidyne Appoints Vice President, Manufacturing and Director, Investor Relations
HSMN NewsFeed - 23 Oct 2006
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
Additional items found! 7
Members Archive contains
7 additional stories matching:
Replidyne
(Password required)
Replidyne
(Password required)
